FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2806072869> ?p ?o ?g. }

• W2806072869 endingPage "1361" @default.
• W2806072869 startingPage "1355" @default.
• W2806072869 abstract "Background The effect of different lipid emulsions (LEs) within the parenteral nutrition (PN) regimen of adult home PN (HPN) patients is not clear. This study investigated the effect of changing adult HPN patients from a soybean oil based LE (Intralipid) to either a fish oil containing LE (providing n-3 fatty acids) (SMOFLipid) or an olive oil based LE (ClinOleic). Methods Thirty two adults receiving long-term HPN with Intralipid as the LE were transferred to receive either SMOFLipid (n = 13) or ClinOleic (n = 19) for 60 days. Liver function markers, cholesterol, triglycerides, a full profile of fatty acids, and several cytokines were measured at study entry and after 60 days. Results SMOFLipid did not affect liver function markers, blood lipids or plasma cytokines. ClinOleic lowered both gamma-glutamyltranspeptidase (P = 0.044) and interleukin-8 (P = 0.030) concentrations. Both LEs induced marked changes in the fatty acid profile of plasma. SMOFLipid resulted in significant decreases in the proportions of linoleic acid, several other n-6 fatty acids and the essential fatty acid (EFA) deficiency indicator mead acid and significant increases in the proportions of the n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid. ClinOleic resulted in significant decreases in the proportions of some saturated fatty acids, linoleic acid, several n-6 fatty acids, all n-3 fatty acids and mead acid and a significant increase in the proportion of oleic acid. The ratio of mead to arachidonic acid in plasma was not altered by either SMOFLipid or ClinOleic. No patient had a mead acid to arachidonic acid ratio of >0.2, the cut-off used to indicate EFA deficiency. Conclusion Both SMOFLipid and ClinOleic significantly alter the fatty acid profile of plasma in adult HPN patients previously using Intralipid. Neither LE induces EFA deficiency in these patients. SMOFLipid did not alter liver function markers or inflammation. In contrast, ClinOleic decreased some, though not all, markers of liver function and inflammation. SMOFLipid and ClinOleic may both be considered for use in adult HPN patients. The effect of different lipid emulsions (LEs) within the parenteral nutrition (PN) regimen of adult home PN (HPN) patients is not clear. This study investigated the effect of changing adult HPN patients from a soybean oil based LE (Intralipid) to either a fish oil containing LE (providing n-3 fatty acids) (SMOFLipid) or an olive oil based LE (ClinOleic). Thirty two adults receiving long-term HPN with Intralipid as the LE were transferred to receive either SMOFLipid (n = 13) or ClinOleic (n = 19) for 60 days. Liver function markers, cholesterol, triglycerides, a full profile of fatty acids, and several cytokines were measured at study entry and after 60 days. SMOFLipid did not affect liver function markers, blood lipids or plasma cytokines. ClinOleic lowered both gamma-glutamyltranspeptidase (P = 0.044) and interleukin-8 (P = 0.030) concentrations. Both LEs induced marked changes in the fatty acid profile of plasma. SMOFLipid resulted in significant decreases in the proportions of linoleic acid, several other n-6 fatty acids and the essential fatty acid (EFA) deficiency indicator mead acid and significant increases in the proportions of the n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid. ClinOleic resulted in significant decreases in the proportions of some saturated fatty acids, linoleic acid, several n-6 fatty acids, all n-3 fatty acids and mead acid and a significant increase in the proportion of oleic acid. The ratio of mead to arachidonic acid in plasma was not altered by either SMOFLipid or ClinOleic. No patient had a mead acid to arachidonic acid ratio of >0.2, the cut-off used to indicate EFA deficiency. Both SMOFLipid and ClinOleic significantly alter the fatty acid profile of plasma in adult HPN patients previously using Intralipid. Neither LE induces EFA deficiency in these patients. SMOFLipid did not alter liver function markers or inflammation. In contrast, ClinOleic decreased some, though not all, markers of liver function and inflammation. SMOFLipid and ClinOleic may both be considered for use in adult HPN patients." @default.
• W2806072869 created "2018-06-13" @default.
• W2806072869 creator A5018290358 @default.
• W2806072869 creator A5025159778 @default.
• W2806072869 creator A5030147478 @default.
• W2806072869 creator A5059049938 @default.
• W2806072869 creator A5059061932 @default.
• W2806072869 creator A5066362474 @default.
• W2806072869 creator A5073023612 @default.
• W2806072869 creator A5074645101 @default.
• W2806072869 creator A5077654575 @default.
• W2806072869 date "2019-06-01" @default.
• W2806072869 modified "2023-10-18" @default.
• W2806072869 title "Effect of changing the lipid component of home parenteral nutrition in adults" @default.
• W2806072869 cites W1528306264 @default.
• W2806072869 cites W2000537420 @default.
• W2806072869 cites W2073942915 @default.
• W2806072869 cites W2106187261 @default.
• W2806072869 cites W2114841940 @default.
• W2806072869 cites W2119821061 @default.
• W2806072869 cites W2125778252 @default.
• W2806072869 cites W212643890 @default.
• W2806072869 cites W2127504862 @default.
• W2806072869 cites W2139729174 @default.
• W2806072869 cites W2143307989 @default.
• W2806072869 cites W2143659187 @default.
• W2806072869 cites W2144891204 @default.
• W2806072869 cites W2152716384 @default.
• W2806072869 cites W2180025784 @default.
• W2806072869 cites W2252662712 @default.
• W2806072869 cites W2256788068 @default.
• W2806072869 cites W2297648000 @default.
• W2806072869 cites W2493954387 @default.
• W2806072869 cites W2563875151 @default.
• W2806072869 cites W2753023607 @default.
• W2806072869 cites W2754394790 @default.
• W2806072869 doi "https://doi.org/10.1016/j.clnu.2018.05.028" @default.
• W2806072869 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29907355" @default.
• W2806072869 hasPublicationYear "2019" @default.
• W2806072869 type Work @default.
• W2806072869 sameAs 2806072869 @default.
• W2806072869 citedByCount "17" @default.
• W2806072869 countsByYear W28060728692019 @default.
• W2806072869 countsByYear W28060728692020 @default.
• W2806072869 countsByYear W28060728692021 @default.
• W2806072869 countsByYear W28060728692022 @default.
• W2806072869 countsByYear W28060728692023 @default.
• W2806072869 crossrefType "journal-article" @default.
• W2806072869 hasAuthorship W2806072869A5018290358 @default.
• W2806072869 hasAuthorship W2806072869A5025159778 @default.
• W2806072869 hasAuthorship W2806072869A5030147478 @default.
• W2806072869 hasAuthorship W2806072869A5059049938 @default.
• W2806072869 hasAuthorship W2806072869A5059061932 @default.
• W2806072869 hasAuthorship W2806072869A5066362474 @default.
• W2806072869 hasAuthorship W2806072869A5073023612 @default.
• W2806072869 hasAuthorship W2806072869A5074645101 @default.
• W2806072869 hasAuthorship W2806072869A5077654575 @default.
• W2806072869 hasBestOaLocation W28060728692 @default.
• W2806072869 hasConcept C126322002 @default.
• W2806072869 hasConcept C134018914 @default.
• W2806072869 hasConcept C181199279 @default.
• W2806072869 hasConcept C185592680 @default.
• W2806072869 hasConcept C19038510 @default.
• W2806072869 hasConcept C2776091944 @default.
• W2806072869 hasConcept C2777171753 @default.
• W2806072869 hasConcept C2777300220 @default.
• W2806072869 hasConcept C2778078955 @default.
• W2806072869 hasConcept C2779885280 @default.
• W2806072869 hasConcept C2779946292 @default.
• W2806072869 hasConcept C2780809830 @default.
• W2806072869 hasConcept C2781403372 @default.
• W2806072869 hasConcept C2909208804 @default.
• W2806072869 hasConcept C2992208098 @default.
• W2806072869 hasConcept C505870484 @default.
• W2806072869 hasConcept C543025807 @default.
• W2806072869 hasConcept C55493867 @default.
• W2806072869 hasConcept C71924100 @default.
• W2806072869 hasConcept C78722104 @default.
• W2806072869 hasConcept C86803240 @default.
• W2806072869 hasConceptScore W2806072869C126322002 @default.
• W2806072869 hasConceptScore W2806072869C134018914 @default.
• W2806072869 hasConceptScore W2806072869C181199279 @default.
• W2806072869 hasConceptScore W2806072869C185592680 @default.
• W2806072869 hasConceptScore W2806072869C19038510 @default.
• W2806072869 hasConceptScore W2806072869C2776091944 @default.
• W2806072869 hasConceptScore W2806072869C2777171753 @default.
• W2806072869 hasConceptScore W2806072869C2777300220 @default.
• W2806072869 hasConceptScore W2806072869C2778078955 @default.
• W2806072869 hasConceptScore W2806072869C2779885280 @default.
• W2806072869 hasConceptScore W2806072869C2779946292 @default.
• W2806072869 hasConceptScore W2806072869C2780809830 @default.
• W2806072869 hasConceptScore W2806072869C2781403372 @default.
• W2806072869 hasConceptScore W2806072869C2909208804 @default.
• W2806072869 hasConceptScore W2806072869C2992208098 @default.
• W2806072869 hasConceptScore W2806072869C505870484 @default.
• W2806072869 hasConceptScore W2806072869C543025807 @default.
• W2806072869 hasConceptScore W2806072869C55493867 @default.
• W2806072869 hasConceptScore W2806072869C71924100 @default.

• next